Package 71993-304-60

Brand: orphenadrine citrate, aspirin and caffeine

Generic: orphenadrine citrate, aspirin and caffeine
NDC Package

Package Facts

Identity

Package NDC 71993-304-60
Digits Only 7199330460
Product NDC 71993-304
Description

60 TABLET in 1 BOTTLE, PLASTIC (71993-304-60)

Marketing

Marketing Status
Marketed Since 2022-03-18
Brand orphenadrine citrate, aspirin and caffeine
Generic orphenadrine citrate, aspirin and caffeine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "414d35d9-b9a2-d717-e063-6294a90a9415", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "upc": ["0371993304605"], "unii": ["R16CO5Y76E", "3G6A5W338E", "X0A40N8I4S"], "rxcui": ["994528"], "spl_set_id": ["61ca2af1-081c-411c-90ce-ec6d9e3157b2"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Atland Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE, PLASTIC (71993-304-60)", "package_ndc": "71993-304-60", "marketing_start_date": "20220318"}], "brand_name": "Orphenadrine Citrate, Aspirin and Caffeine", "product_id": "71993-304_414d35d9-b9a2-d717-e063-6294a90a9415", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Centrally-mediated Muscle Relaxation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Muscle Relaxant [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "71993-304", "generic_name": "Orphenadrine Citrate, Aspirin and Caffeine", "labeler_name": "Atland Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Orphenadrine Citrate, Aspirin and Caffeine", "active_ingredients": [{"name": "ASPIRIN", "strength": "385 mg/1"}, {"name": "CAFFEINE", "strength": "30 mg/1"}, {"name": "ORPHENADRINE CITRATE", "strength": "25 mg/1"}], "application_number": "ANDA075141", "marketing_category": "ANDA", "marketing_start_date": "20220318", "listing_expiration_date": "20261231"}